Meeting details menu

Meeting Authors
Meeting Abstracts
Keynote lectures
Oral communications
Poster presentations
Special symposia
Other

Acta Physiologica Congress

Back

Acta Physiologica 2011; Volume 203, Supplement 687
First Benelux Congress on Physiology and Pharmacology
3/18/2011-3/19/2011
Liège, Belgium


THE EFFECTS OF METHYLSUFONYLMETHANE (MSM) ON INFLAMMATORY MARKERS IN MONOCROTALINE-INDUCED PULMONARY HYPERTENSION
Abstract number: PO-09

MSM is naturally accruing organic sulphur that is known as a potent anti-oxidant/anti-inflammatory compound. The aim of this study was to investigate the effect of MSM on hemodynamics functions in rats with monocrotaline (MCT)-induced pulmonary arterial hypertension (PAH). Wistar rats were randomly assigned to 38-days pretreatment or 28-days treatment. MSM was administered to rats at 100, 200, and 400 mg/kg/day doses either 10 days before or after a single dose of 60 mg/kg, IP, MCT. Rats were anesthetized with pentobarbital and heart tissue samples were obtained to evaluate changes in the antioxidative system and inflammatory genes expression levels including endotheline-1 (ET-1), transforming growth factor-b1 (TGF-b1), angiotensinogen. Analyses of gene expression by RT-PCR found a significantly reduced ET-1, TGF-b1 and angiotensinogen levels at efficient dose in MCT-induced pulmonary arterial hypertensive rats. There was also a similar, non-significant trend for the treatment protocol. Our present results suggest that long term administration of the MSM attenuates MCT-induced PAH related inflammation in rats. Should similar effects of MSM be found on markers of oxidative stress, this may have promise in the treatment and prevention of PAH.

To cite this abstract, please use the following information:
Acta Physiologica 2011; Volume 203, Supplement 687 :PO-09

Our site uses cookies to improve your experience.You can find out more about our use of cookies in our standard cookie policy, including instructions on how to reject and delete cookies if you wish to do so.

By continuing to browse this site you agree to us using cookies as described in our standard cookie policy .

CLOSE